Figure 1 Challenges and opportunities of using omics in EDC research

Slides:



Advertisements
Similar presentations
Nat. Rev. Endocrinol. doi: /nrendo
Advertisements

Figure 2 Electromechanical properties of OIHPs
Figure 6 Selected examples of TERS applications in material systems
Figure 3 Childhood craniopharyngioma
Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.
Figure 2 Regions of Africa exposed to undernutrition
Figure 7 Mendelian randomization of overlapping exposures
Figure 2 Pathophysiology of hyperglycaemia in T2DM
with undiagnosed diabetes mellitus by three diagnostic criteria
Figure 4 Amino acid structure of short-acting and long-acting insulins
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Adverse effects in women treated with HRT
Figure 1 Monogenic forms of diabetes mellitus
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Urol. doi: /nrurol
Figure 2 Circadian and ultradian fluctuations in corticosterone
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Intracellular regulation of the glucocorticoid receptor
Figure 1 Intensity-based loading options to increase bone strength
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Acute kidney injury and chronic kidney disease
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Osteosarcoma epidemiology
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Oestrogen biosynthesis and production sites in the body
Figure 1 The development process of the Asian
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Health-care system today
Figure 2 Pharmacokinetic action profiles of rapid-acting insulins
Figure 4 Tracheal endoscopy in two patients
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Serum levels of TSH and free T4 in a large series
Figure 3 Statistical approaches for the analysis of metabolomic data
Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.
Figure 1 Cardiovascular risk and disease across the life-course
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 BMPs in brown and beige adipogenesis and function
Figure 3 Challenges for big data applications in cardiovascular care
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Pharmacodynamic action profiles of long-acting insulins
Figure 5 Systems biological model of IBS
Figure 6 Joint morphogenesis
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Figure 1 A large number of genes are potentially associated with CIPN
Figure 2 Impaired mitochondrial capacity and function in heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Oxidative phosphorylation
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Global iodine status and mandatory salt iodization
Bacteriophage DNA Packaging
On the Etruscan Mitochondrial DNA Contribution to Modern Humans
Nat. Rev. Endocrinol. doi: /nrendo
Presentation transcript:

Figure 1 Challenges and opportunities of using omics in EDC research Figure 1 | Challenges and opportunities of using omics in EDC research. Schematic representation of the sequence of steps from production of chemicals to endocrine-disrupting chemical (EDC) exposure, from toxicological research to human studies, and from challenges with exposure characterization and risk prediction to the anticipated goals and opportunities of applying genomics, epigenomics and mitochondriomics to the field of EDC research. mtDNA, mitochondrial DNA. Messerlian, C. et al. (2017) ‘Omics’ and endocrine-disrupting chemicals — new paths forward Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.81